| Title |
Content Analysis of False and Misleading Claims in Television Advertising for Prescription and Nonprescription Drugs
|
|---|---|
| Published in |
Journal of General Internal Medicine, September 2013
|
| DOI | 10.1007/s11606-013-2604-0 |
| Pubmed ID | |
| Authors |
Adrienne E. Faerber, David H. Kreling |
| Abstract |
False and misleading advertising for drugs can harm consumers and the healthcare system, and previous research has demonstrated that physician-targeted drug advertisements may be misleading. However, there is a dearth of research comparing consumer-targeted drug advertising to evidence to evaluate whether misleading or false information is being presented in these ads. |
X Demographics
The data shown below were collected from the profiles of 22 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 8 | 36% |
| United Kingdom | 1 | 5% |
| India | 1 | 5% |
| Unknown | 12 | 55% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 15 | 68% |
| Science communicators (journalists, bloggers, editors) | 3 | 14% |
| Practitioners (doctors, other healthcare professionals) | 3 | 14% |
| Scientists | 1 | 5% |
Mendeley readers
The data shown below were compiled from readership statistics for 132 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | <1% |
| Unknown | 131 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 26 | 20% |
| Student > Bachelor | 22 | 17% |
| Researcher | 12 | 9% |
| Student > Ph. D. Student | 11 | 8% |
| Other | 7 | 5% |
| Other | 22 | 17% |
| Unknown | 32 | 24% |
| Readers by discipline | Count | As % |
|---|---|---|
| Social Sciences | 16 | 12% |
| Medicine and Dentistry | 15 | 11% |
| Business, Management and Accounting | 13 | 10% |
| Pharmacology, Toxicology and Pharmaceutical Science | 11 | 8% |
| Agricultural and Biological Sciences | 8 | 6% |
| Other | 31 | 23% |
| Unknown | 38 | 29% |
Attention Score in Context
This research output has an Altmetric Attention Score of 134. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 March 2021.
All research outputs
#288,748
of 24,214,995 outputs
Outputs from Journal of General Internal Medicine
#245
of 7,872 outputs
Outputs of similar age
#2,203
of 202,202 outputs
Outputs of similar age from Journal of General Internal Medicine
#1
of 73 outputs
Altmetric has tracked 24,214,995 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 7,872 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 22.0. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 202,202 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 73 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.